About the Queen of Hearts Foundation
Established in 2000, The Queen of Hearts Foundation is a non-profit organization dedicated to raising funds for the research and early detection of ovarian cancer and in promoting public awareness and education about the signs and symptoms of this disease.
We are committed to making a difference in womens' lives. We want the women diagnosed with ovarian cancer to know there is hope for survival. We remain passionate that early detection, early awareness and intelligent medical attention are the keys to fighting this cancer. We are the only foundation in Southern California specifically dedicated to funding ovarian cancer research projects. Learn More »
On March 28th, Ann S. Dobbie would have been 82 years old. This year, please join us for our 2016 Ann’s Birthday to Mother’s Day Crusade – 40 days of fundraising from Ann’s Birthday to Mother’s Day! The Queen of Hearts Foundation is looking for 125 people to join us and donate $40 to honor a special woman in your life. Click on EVENTS tab for details!
5TH ANNUAL LIVE, LOVE, LAUGH AND LEARN SPEAKER’S LUNCHEON AND CHIC BOUTIQUE Tuesday, February 9th, 2016 10AM-3PM THE PACIFIC CLUB, NEWPORT BEACH FEATURING A CONVERSATION WITH Dr. Frank M. LaFerla “Researching Ways to Make Memories Last a Lifetime”
If organizations like QoHF hadn't been doing research on my specific kind of cancer 15 yrs ago, I wouldn't be here today. Your donation may very well end up saving your own life someday.
— Elizabeth Courtney, OvarianCancer Survivor (2004)
There are also no reliable symptoms to allow doctors to catch the disease in its earliest stages. Research efforts are ongoing to develop an effective screening test and better drugs to combat this deadly disease. It is through the research funding support provided by the Queen of Hearts Foundation that these goals are likely to be achieved in the near future.
— Krishnansu Sujata Tewari, MD FACOG FACS Associate Professor, Principal Investigator - Gynecologic Oncology Group at UC Irvine Co-Chair - Clinical Trials Protocol Review & Monitoring Committee